Answers are grounded in this paper and cite their sources.
A report is presented on the development and the properties of a nondegraded human immunoglobulin preparation suitable for intravenous administration. Intravenous tolerance is achieved by elimination of anticomplementary activity through modification with beta-propiolactone. The natural antibody characteristics, such as antibody activity, molecular weight, and half-life, are retained. The findings presented open up new perspectives for an extension of the range of indication for intravenous immunoglobulin.
No takes yet. Share an insight, caveat, or question.
W. Stephan (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: